ユーロフィンジェネティックラボ Product Lineup

Eurofins Genetic Lab Co., Ltd. responds to the needs of healthcare-related companies such as pharmaceutical, food, and cosmetics manufacturers. We support from upstream to downstream in research and development, including molecular pathology analysis and comprehensive analysis in animal testing, as well as measurement evaluations for biomanufacturers in human clinical trials. Furthermore, we provide various methods to establish measurement protocols for the exploration and validation of clinical biomarkers required in future drug development. 【Features】 - Responding to the needs of healthcare-related companies - Support for research and development such as molecular pathology analysis and comprehensive analysis - Provision of methods for establishing measurement protocols, etc. *Please feel free to contact us for more details.

• Other analytical and testing equipment

Genetic Lab Co., Ltd. introduces advanced analytical equipment for measuring and evaluating genes, proteins, and cells, leading the way in Japan. We propose analytical solutions that integrate cutting-edge technology with histopathological methods. In particular, we provide technology capable of measuring and evaluating diffusion in clinical samples fixed with formalin, which is challenging for typical contract analysis companies, as well as in minute tissue sections with ultra-high sensitivity. Additionally, we can broadly accommodate your research needs, from comprehensive genomic analysis to high-throughput quantitative evaluation of selected genes. [Features] - Proposal of analytical solutions that integrate cutting-edge technology and histopathological methods - Provision of technology capable of measuring and evaluating diffusion with ultra-high sensitivity - High-throughput quantitative evaluation of genes, etc. *Please feel free to contact us for more details.

• Analysis and sequencing services

Genetic Lab Co., Ltd. utilizes its core technology of pathological diagnostic techniques and cutting-edge molecular biology-related technologies to promote the exploration and evaluation of biomarkers, diagnostic methods, and the development of diagnostic drugs. Additionally, we have launched a new service that merges our two business areas, offering a "biomarker exploration and evaluation service" using organizational pathological methods and advanced analytical technologies. We aim to establish this new service as the third pillar of our business and respond to the development of diversified treatments and diagnostics, including personalized medicine, which is expected to grow in the future. [Features] - Contributing to regional healthcare through pathological diagnosis - Actively supporting research and development in dramatically evolving cutting-edge fields - Promoting personalized medicine that will lead the next generation *For more details, please refer to our catalog or feel free to contact us.

• Microarrays and DNA chips